Back to Journals » International Journal of General Medicine » Volume 14

Efficacy and Safety of Anlotinib Monotherapy as Third-Line Therapy for Elderly Patients with Non-Small Cell Lung Cancer: A Real-World Exploratory Study

Total article views   HTML views PDF downloads Totals
2,944 Dovepress* 2,632+ 125 2,757
PubMed Central* 312 126 438
Totals 2,944 251 3,195
*Since 2 November 2021
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 1 2 6

View citations on PubMed Central and Google Scholar